These are Friday’s market winners and losers.
Biggest Winners
Shares of Halozyme Therapeutics Inc. (NASDAQ: HALO) are up 26.52% to $8.11 on trading volume of 2 million shares. The U.S. Food and Drug Administration has provided guidance to Halozyme and ViroPharma Inc. (NASDAQ: VPHM) to resume clinical studies of the drug Cinryze. The 52-week high is $13.50.
Shares of KB Home (NYSE: KBH) are up 9.38% to $14.34 on trading volume of 7 million shares. The company earned 4 cents a share in the third quarter, better than a loss of 12 cents a share that Wall Street analysts polled by Reuters were expecting. Before Friday, the 52-week high was $13.65.
Biggest Losers
Shares of VIVUS Inc. (NASDAQ: VVUS) are down 10.58% to $21.21 on trading volume of 4.7 million shares. The pharmaceutical company is concerned that European regulators will reject its anti-obesity drug. The 52-week low is $7.47.
Shares of Research In Motion Ltd. (NASDAQ: RIMM) are down 5.58% to $6.52 on trading volume of 10.4 million shares. Blackberry suffered service outages in Europe, the Middle East and Africa. The 52-week low is $6.33.
Samuel Weigley
Follow him on Twitter: SWeigley
Essential Tips for Investing (Sponsored)
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.